Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Equity Ratio (2024 - 2025)

Kairos Pharma's Equity Ratio history spans 2 years, with the latest figure at 0.97 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 17.1% year-over-year to 0.97; the TTM value through Dec 2025 reached 0.97, up 17.1%, while the annual FY2025 figure was 0.97, 17.1% up from the prior year.
  • Equity Ratio reached 0.97 in Q4 2025 per KAPA's latest filing, up from 0.9 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.97 in Q4 2025 to a low of 0.67 in Q3 2024.